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In recent years there has been a growing interest for the development of tubular scaffolds employed to assist the replacement of small blood vessels. Materials designed for this purpose need to be biodegradable, have good mechanical properties and improve cell adhesion, proliferation and differentiation. To obtain biomaterials with these properties, electrospinning seems to be one of the most useful technique. Several biodegradable synthetic polymers or constituents of the extracellular matrix (ECM)  have been electrospun showing optimal mechanical properties and biodegradability. However, such polymers are lacking in versatile chemical structure affordable to immobilize growth factors or chemokines. The glycosaminoglycan heparin is able to bind several growth factors like vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) and, when grafted onto the scaffold surface  it is able to attract cells thus improving their proliferation and differentiation. 
Aim of this research was the production and the preliminary in vitro biological characterization of a new biodegradable material, obtained by electrospun a polyaminoacid-graft-polyester copolymer. The electrospun biomaterial has been successfully grafted with heparin exploiting the better chemical reactivity of the polyaminoacid portions of the graft copolymer. Then its morphology  has been investigated by scanning electron microscopy (SEM) and the potential biodegradability of the material has been studied until  60 days. Preliminary biological data in vitro, on human endothelial cells, show a good compatibility of the scaffold obtained by electrospinning, with regard to cell adhesion and proliferation. Experiments are in progress to evaluate the effects of heparin on cell differentiation.

1. Introduction
In the last years there has been a rising interest among tissue engineering community for the development of small-sized blood vessels substitutes (Sheridan et al, 2012,  Pooyan et al 2012, Nottelet et al, 2009). 
Each year,  there is a strong patient demand for vascular bypass graft due to atherosclerosis and other cardiovascular diseases that are still the leading cause of mortality in the western countries.
Several studies have been focused on the development of a biodegradable vascular graft able to substitute only temporary the blood vessel and allows its complete regeneration after a certain time.  
For this purpose, the gold standard material must be biodegradable, to show optimal mechanical characteristics (to resist to the blood stream) and an optimal capacity to allow cell adhesion, differentiation and proliferation.
The biodegradation rate of the system should be adequate in order to allow, for the time necessary to the cells to produce the new tissue,  the mechanical stability of the vascular graft, and its complete degradation   after the new vessel is formed.
To develop a biomaterial with these properties, electrospinning seems to be one of the most useful technique due to the possibility to obtain nano-fibrillar scaffolds starting from polymeric solution.
Peculiar properties of electrospun scaffolds make them as optimal candidates for several regenerative medicine applications. Actually, the  size (ranging from 200 nm to 2µm), shape and geometrical distribution in the space  of the fibers  obtained from the electrospinning, are highly similar to the collagen fibrils present in the natural ECM.
Also, the disordered arrangement of electrospun fibers, allows a distribution of the mechanical forces applied to the material resulting in an increase in scaffold mechanical resistance.
Several biodegradable synthetic polymers like poly(lactide acid) (PLA), polycaprolactone (PCL) (Vaz et al, 2005), and natural polymeric materials like collagen  (Li et al, 2005) have been electrospun with the aim to develop a successful vascular graft.
However, due to the lack of suitable mechanical properties, the unsuitable rate of biodegradation and the poor capacity to create an optimal microenvironment for cell adhesion and differentiation, none of these materials seems to be appropriate for further application in the human body. 
Besides,  another limitation of the current used polymers  is the lack of a versatile chemical structure.
Due to a scarce number of derivatizable functions, these polymers cannot be exploited to link active molecules like growth factors, chemokines and heparin that allow the material to be recognized as “self” from the body offering an optimal substratum for cell attachment and proliferation.
Heparin is an anticoagulant sulfate glycosaminoglycan (Ishihara and Ono, 1998) physiologically produced in the body, its hydroxyl and carboxyl groups are the main functional groups contributing to its anticoagulant activity. Heparin is also able to bind growth factors like vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) (Jayson and Gallagher, 1997) (Soker et al, 1994) and could be exploited to improve the ability of a biomaterial to allow cell attachment and proliferation.
Here we report the production of a new biodegradable material, by the electrospinning of  an innovative  polyaminoacid- graft-polyester copolymer able to be functionalized with heparin, for a potential use in tubular structures  for  vascular regenerative medicine.

2. Experimental 
Electrospinning polymeric solution was prepared in a mixture dimethylformamide/dichlorometane 50:50 v/v. The solution was loaded into a 5 ml plastic syringe fitted with a needle having a diameter of 0.8 mm.
Electrospinning process was carried out horizontally with an accelerating voltage of 20 kV supplied by a high voltage power supply. A syringe pump was used to feed the polymeric solution into the needle tip at a constant rate of 2 ml/h.
The electrospun scaffold was collected on an aluminium foil (15 cm by 10 cm) wrapped around an earthed rotating collector (200 rpm) 25 cm from the tip of the needle.
The resulting fibrillar scaffold was dried under vacuum at room temperature for 3–4 days.
The morphology of the scaffold was evaluated by scanning electron microscopy (SEM).
The heparinization of the scaffold was performed in 2-(N-morpholino)ethanesulfonic acid medium (MES), having a pH of 5.5 at 37°C.
The scaffold was washed with different saline solutions and then with water to eliminate the unreacted heparin and the excess of salt, respectively.
The degradation of the scaffold was investigated by incubating the samples in phosphate buffer pH 7.4 at 37°C. At scheduled times, samples were washed several times with distilled water, freeze dried and weighed. The degradation was calculated comparing the final weight with the initial one, and it was reported as loss of weight %. 
A toulidine blue colorimetric assay was used to determine the amount of heparin chemically linked to scaffold surface. In vitro degradation studies have been performed in simulated physiological medium. 
Cell culture. For biological assay, ECV304 human endothelial cells, from ECACC (European Collection of Cell Cultures), cultured in Midium199 added with 1% antibiotic, 1% glutamine and 10% Fetal Calf Serum (FCS) were used.
Cell proliferation assay by MTS test.The ECV304 cells were seeded on scaffolds in 12 well plate, at density of 20.000 cells/well in MEM199 complete medium and incubated respectively for 24h and 48h  at 37°C in a humidified 5% CO2 atmosphere. Control cells were seeded on plate.




A very important outset in tissue engineering is the development of a biomaterial able not only to allow  in vitro and in vivo cell adhesion, differentiation and spreading, but also to be recognized as “self” from the organism when it comes in contact with native tissues.
In other words, the bioengineered material must be able to interact with the host tissues both mechanically and biochemically. 
For this reason, the chemical versatility of the starting material offers an interesting opportunity to obtain a scaffold bearing bioactive molecules onto its surface able to minimize the physiological gap between native tissues and the bioengineered one.    
Still, the fabrication technique of the scaffold could be crucial in obtaining a biomaterial morphologically similar  to the tissue that must be replaced.
Here, with the aim to produce a new biomaterial potentially suitable for the production of a bioengineered blood vessel, we have electrospun a highly functionalizable polyaminoacid-graft-polyester copolymer.
The obtained scaffold shows morphological characteristics similar to those of natural extracellular matrix, a suitable rate of degradation in simulated physiological medium (after 60 days 50% about of the scaffold is degraded), ability to be easily functionalizable and to allow endothelial cell adhesion and proliferation. Figure 1 shows a SEM image of the obtained scaffold.

    	
                 

                       Figure 1 - SEM image of obtained fibrillar scaffold 




Figure 2- Evaluation of cell viability by MTS assay as absorbance values as a function of time. The test was carried out on scaffolds with and without heparin. The MTS assay was carried out in the well after removing the scaffold and on the scaffold alone put in a new plate. Cell growth directly on plate was used as a control. 


As shown in Figure 2, the absorbance data, obtained by the spectrophotometric reading, which are considered to be directly proportional to the number of metabolically active cells present in various samples, show the  viability over time of the cells grown on the polymeric electrospun scaffold (Figure 2 a-b) containing or not heparin (EPA). Despite having started from the same initial number of cells (20.000cells/well) the final number of cells is lower on both types of scaffolds compared to controls on the plate; this is due to a certain amount of cells that initially slide on the bottom of the well. Nevertheless, it is possible to show a slight cell proliferation over time, on the scaffold plus heparin, (Figure 2-a) than without heparin (Figure 2-b).

4. Conclusions
A fibrillar scaffold able to be functionalized with bioactive molecules, potentially employed for the regeneration of vascular structure was successfully produced by the technique of the electrospinning.
The heparinization of the obtained scaffold was conducted by a simple and reproducible chemistry.
The amount of linked heparin, calculated via colorimetric assay, could perform biological function  both in vitro and in vivo.
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